FO

FT Options LLC

Diversified strategyHigh-turnover traderSector-focused

Total reported value

$66.4M

Reporting period: 2017-09-30 · Number of holdings: 229

FT Options LLC disclosed 229 holdings in its latest 13F filing for the period ending 2017-09-30, with total reported value of $66.4M and a quarterly turnover rate of 103.4%.

Browse other institutions with under $100M AUMBrowse other institutions starting with "F"

Personality snowflake

Concentration
11.42
Portfolio Stability
100
Momentum/Contrarian
100
Sector conviction
100
Diversification
100
Sizing Uniformity
85.11

Recent moves

  • Trim CLVSEUR

    -38.1%　-$4.1M

  • Add INCY

    +168.0%　$3.7M

  • Trim GIS

    -50.1%　-$2.8M

  • Trim ABT

    -54.5%　-$2.0M

  • Add ALNY

    +509.5%　$1.8M

  • Trim CLX

    -57.5%　-$1.2M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

Showing top 112 holdings (of 229 total)

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1GWPHGw Pharmaceuticals LTDStock-Other7.68%-0.35%+21.49%
2INCYIncyte CORPStock-Healthcare6.36%+5.41%+167.98%
3CLVSEURClovis Oncology INCStock-Other5.23%-7.87%-38.09%
4T8STesaro INCStock-Other5.15%+0.71%+8.49%
5TEVATeva Pharmaceutical-sp AdrStock-Healthcare4.26%+4.26%NEW
6ALNYAlnylam Pharmaceuticals INCStock-Healthcare3.20%+2.65%+509.47%
7INSMInsmed INCStock-Healthcare2.77%+1.79%+97.10%
8VRTXVertex Pharmaceuticals INCStock-Healthcare2.71%+0.79%+13.17%
9BABAAlibaba Group Holding-sp AdrStock-Consumer Disc2.58%——
10ICPTUSDIntercept Pharmaceuticals InStock-Other2.53%+2.53%NEW
11AKBAAkebia Therapeutics INCStock-Other2.34%+1.25%+45.64%
12PBYIPuma Biotechnology INCStock-Other2.32%+1.27%-69.24%
13KMBKimberly-clark CORPStock-Consumer Staples2.06%+1.82%+38.87%
14ZGNXEURZogenix INCStock-Other2.01%+2.01%NEW
15✓ Axovant Sciences LTDStock-Other2.00%+1.44%+1144.00%
16IBBIshares Biotechnology ETFETF-Tech2.00%-2.05%-16.95%
17KRGKite Realty Group TrustStock-Real Estate2.00%+0.96%+348.62%
18PLCEChildren's Place Inc/theStock-Other2.00%+2.00%NEW
19GILDGilead Sciences INCStock-Healthcare1.77%+1.77%NEW
20NKENike INC -cl BStock-Consumer Disc1.77%+1.77%NEW
21BMYBristol-myers Squibb CoStock-Healthcare1.61%+1.00%+104.98%
22HSICHenry Schein INCStock-Healthcare1.59%+1.59%NEW
23✓ Stock-Other1.51%+1.51%NEW
24ALXNAlexion Pharmaceuticals INCStock-Other1.42%+1.42%NEW
25✓ Versartis INCStock-Other1.41%+1.41%NEW
26MDLZMondelez International Inc-aStock-Consumer Staples1.31%-1.45%-7.84%
27TWXCHFTime Warner INCStock-Other1.31%+0.73%+48.80%
28BUDAnheuser-busch Inbev-spn AdrStock-Consumer Staples1.28%—-41.85%
29ABTAbbott LaboratoriesStock-Healthcare1.27%-3.65%-54.47%
30DVAXDynavax Technologies CORPStock-Other1.20%—-72.35%
31OTICEUROtonomy INCStock-Other1.20%-1.07%+39.81%
32SRPTSarepta Therapeutics INCStock-Healthcare1.17%—+76.55%
33REGNRegeneron PharmaceuticalsStock-Healthcare1.07%—-28.99%
34AM6Amicus Therapeutics INCStock-Other1.02%+0.57%+78.41%
35ABBVAbbvie INCStock-Healthcare1.01%+0.96%+327.01%
36AIMTAimmune Therapeutics INCStock-Other1.00%+1.00%NEW
37DVADavita INCStock-Healthcare0.91%-0.92%-28.33%
38SG7Sage Therapeutics INCStock-Other0.91%—-24.30%
39✓ Scynexis INC Com NewStock-Other0.88%—-3.98%
40QSRRestaurant Brands InternStock-Consumer Disc0.79%+0.79%NEW
41✓ Cascadian TherapeuticsStock-Other0.72%—-6.45%
42ESPREsperion Therapeutics INCStock-Other0.67%+0.64%-73.61%
43PTCTPtc Therapeutics INCStock-Healthcare0.61%+0.61%NEW
44WMTWalmart INCStock-Consumer Staples0.61%+0.61%NEW
45DERMEURDermira INCStock-Other0.57%——
46CLXClorox CompanyStock-Consumer Staples0.53%-2.09%-57.54%
47✓ Stock-Other0.48%——
48GISGeneral Mills INCStock-Consumer Staples0.46%-4.88%-50.15%
49AERIEURAerie Pharmaceuticals INCStock-Other0.40%—+8.70%
50ISRGIntuitive Surgical INCStock-Healthcare0.38%—-55.45%
1–50 of 112

Holding changes this quarter

FT Options LLC's most significant position changes for 2017-09-30: New buy: Teva Pharmaceutical-sp Adr (TEVA); Sold out: Portola Pharmaceuticals INC (PTLAEUR); Sold out: Amgen INC (AMGN); New buy: Intercept Pharmaceuticals In (ICPTUSD); New buy: Zogenix INC (ZGNXEUR).

Position changes disclosed by FT Options LLC for the quarter ending 2017-09-30, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1INCYIncyte CORP+5.4%+167.98%Add
2ALNYAlnylam Pharmaceuticals INC+2.7%+509.47%Add
3KMBKimberly-clark CORP+1.8%+38.87%Add
4INSMInsmed INC+1.8%+97.10%Add
5✓ Axovant Sciences LTD+1.4%+1144.00%Add
6PBYIPuma Biotechnology INC+1.3%-69.24%Trim
7AKBAAkebia Therapeutics INC+1.3%+45.64%Add
8BMYBristol-myers Squibb Co+1%+104.98%Add
9KRGKite Realty Group Trust+1%+348.62%Add
10ABBVAbbvie INC+1%+327.01%Add
11VRTXVertex Pharmaceuticals INC+0.8%+13.17%Add
12TWXCHFTime Warner INC+0.7%+48.80%Add
13T8STesaro INC+0.7%+8.49%Add
14ESPREsperion Therapeutics INC+0.6%-73.61%Trim
15AM6Amicus Therapeutics INC+0.6%+78.41%Add
16GWPHGw Pharmaceuticals LTD-0.4%+21.49%Add
17PNWPinnacle West Capital Corporation-0.7%-0.37%Trim
18DVADavita INC-0.9%-28.33%Trim
19POT1EURPotash CORP Of Saskatchewan-1%-91.40%Trim
20OTICEUROtonomy INC-1.1%+39.81%Add
21MDLZMondelez International Inc-a-1.5%-7.84%Trim
22CLColgate-palmolive Co-1.9%-45.65%Trim
23KELKellanova-2%-85.14%Trim
24IBBIshares Biotechnology ETF-2.1%-16.95%Trim
25CLXClorox Company-2.1%-57.54%Trim
26ABTAbbott Laboratories-3.7%-54.47%Trim
27GISGeneral Mills INC-4.9%-50.15%Trim
28CLVSEURClovis Oncology INC-7.9%-38.09%Trim
29TEVATeva Pharmaceutical-sp Adr—NEWNew buy
30PTLAEURPortola Pharmaceuticals INC—EXITSold out
31AMGNAmgen INC—EXITSold out
32ICPTUSDIntercept Pharmaceuticals In—NEWNew buy
33ZGNXEURZogenix INC—NEWNew buy
34PLCEChildren's Place Inc/the—NEWNew buy
35GILDGilead Sciences INC—NEWNew buy
36NKENike INC -cl B—NEWNew buy
37HSICHenry Schein INC—NEWNew buy
38✓ —NEWNew buy
39ALXNAlexion Pharmaceuticals INC—NEWNew buy
40MDCOUSDMedicines Company—EXITSold out
41✓ Versartis INC—NEWNew buy
42CELGCelgene CORP—EXITSold out
43AIMTAimmune Therapeutics INC—NEWNew buy
44DISWalt Disney Co/the—EXITSold out
45QSRRestaurant Brands Intern—NEWNew buy
46✓ Mallinckrodt PLC—EXITSold out
47XBISs Spdr S&p Biotech ETF—EXITSold out
48PTCTPtc Therapeutics INC—NEWNew buy
49WMTWalmart INC—NEWNew buy
50COSTCostco Wholesale CORP—EXITSold out

FAQ

What is FT Options LLC and what type of investor is it?
FT Options LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2017-09-30), the firm manages a tracked equity portfolio valued at approximately $66.4M, spread across 229 disclosed positions.
What are FT Options LLC's largest equity positions?
Based on the latest 13F filing, FT Options LLC's top holdings by market value are: 1. Gw Pharmaceuticals LTD (GWPH) — $5.1M (7.7%) 2. Incyte CORP (INCY) — $4.2M (6.4%) 3. Clovis Oncology INC (CLVSEUR) — $3.5M (5.2%) 4. Tesaro INC (T8S) — $3.4M (5.2%) 5. Teva Pharmaceutical-sp Adr (TEVA) — $2.8M (4.3%)
What changes did FT Options LLC make in its most recent portfolio filing?
In the latest reported quarter, FT Options LLC made 50 notable position adjustments: 14 new positions were initiated, 15 existing holdings were added to, 13 positions were partially reduced, and 8 were completely exited. The largest of these moves: New buy: Teva Pharmaceutical-sp Adr (TEVA); Sold out: Portola Pharmaceuticals INC (PTLAEUR); Sold out: Amgen INC (AMGN); New buy: Intercept Pharmaceuticals In (ICPTUSD); New buy: Zogenix INC (ZGNXEUR)
What sectors does FT Options LLC focus on?
FT Options LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 63.7% • Consumer Discretionary: 27.9% • Consumer Staples: 6.3% • Financials: 1.4% • Communication Services: 0.7%

Peer Institutions

Institutions with a similar AUM

BI

Breachway Investments LLC

Total reported value

$66.4M

74 stks

2026-06-30

Concentration10.4
Portfolio Stability53.9
Sector conviction93.4

AUM within 0.1% of this institution

View detail
SG

Sip Global Opportunity Manager LLC

Total reported value

$66.3M

1 stks

2026-03-31

Concentration100.0
Portfolio Stability44.6
Sector conviction0.0

AUM within 0.1% of this institution

View detail
FC

Fairpointe Capital LLC

Total reported value

$66.3M

114 stks

2021-03-31

Concentration12.2
Portfolio Stability100.0
Sector conviction100.0

AUM within 0.1% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

BJ

Blue Jay Capital Management, LLC

Total reported value

$146.8M

20 stks

2017-06-30

Concentration20.8
Portfolio Stability95.3
Sector conviction100.0

3 of the top 5 holdings overlap, including Tesaro INC

View detail
SS

Sound Shore Management INC /ct/

Total reported value

$3.0B

40 stks

2026-03-31

Concentration10.8
Portfolio Stability61.9
Sector conviction42.7

1 of the top 5 holdings overlap, including Teva Pharmaceutical-sp Adr

View detail
PT

Pear Tree Advisors INC

Total reported value

$238.1M

106 stks

2016-06-30

Concentration33.2
Portfolio Stability20.7
Sector conviction100.0

1 of the top 5 holdings overlap, including Teva Pharmaceutical-sp Adr

View detail